APA (7th ed.) Citation

T, S., A, M., M, S., T, O., Y, S., F, K., . . . E, B. (2024). Author Correction: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel. Scientific reports, 14(1), 5311. https://doi.org/10.1038/s41598-024-55673-7

Chicago Style (17th ed.) Citation

T, Shirakawa, et al. "Author Correction: C-reactive Protein/albumin Ratio Is the Most Significant Inflammatory Marker in Unresectable Pancreatic Cancer Treated with FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel." Scientific Reports 14, no. 1 (2024): 5311. https://doi.org/10.1038/s41598-024-55673-7.

MLA (9th ed.) Citation

T, Shirakawa, et al. "Author Correction: C-reactive Protein/albumin Ratio Is the Most Significant Inflammatory Marker in Unresectable Pancreatic Cancer Treated with FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel." Scientific Reports, vol. 14, no. 1, 2024, p. 5311, https://doi.org/10.1038/s41598-024-55673-7.